lobbying_activities: 1875088

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1875088	475547b7-75cd-4d23-8f31-f7cbefbcdbef	Q3	AMERICAN PHARMACISTS ASSOCIATION	3071	AMERICAN PHARMACISTS ASSOCIATION	2016	third_quarter	PHA	Reimbursement of Pharmacist Services (HR592, S314) Transitions of Care Risk Evaluation and Mitigation Services Track and Trace/Supply Chain Health Information Technology Immunizations Compounding Tele-medicine Quality Rating AMP FULs/MAC Pricing Biosimiliars/Biologic Products (S 2700) Drug Importation Generics Labeling Pharmacy Benefit Managers Preferred Pharmacy Network (HR793) Electronic Labeling 21st Century Cures (HR6, HR 350) Drug Disposal/Management Drug Prices Direct and Indirect Remuneration Fees (HR 5951, S 3308) Cody Miller Act (S 2214) Lab Developed Tests	Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)		30000	0	0	2016-10-11T16:31:18.867000-04:00